NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.
NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.
Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.
FDA says new tools needed to speed therapeutics development.
Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.
CDC study finds obesity may become leading preventable cause of death; NIH research plan drafted.
Funding opportunities listed.
Trending Stories
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- How City of Hope is turning microbiome science into better cancer care
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Charles Rudin named cancer center director at MSK
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - What are you reading in 2024?









